| 标题 |
Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Pharmacological Research 作者:Xumin Zhou; Libin Zou; Wenbin Chen; Taowei Yang; Junqi Luo; et al 出版日期:2020-11-14 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)